NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
29/07/2026
Voltar para busca
Dado oficial do USPTO
BTG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
72
Atualização mais recente
29/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
18/08/2014
Data de registro
24/05/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/07/2026
Última transação
29/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
24
Localização do titular
London, GB
Examinador
JACKSON, ELIZABETH FLEMING
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a shaded circle with four diagonal narrowing notches inside of it; below the circle are the letters "BTG" in stylized lettering.
Titulares e representantes
Titulares
PROTHERICS MEDICINES DEVELOPMENT LIMITED
BTG International Limited
BTG International Limited
Representantes
Jonathan A. Hyman Knobbe, Martens, Olson & Bear, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalmedicinal and veterinary preparations and substancesvaccinesantitoxic serapharmaceutical preparations for the treatment of cancerpharmaceutical preparations and substances for the treatment of thrombosisembolismsinflammationautoimmune diseasepharmaceutical preparations for the treatment of envenomation by snakesveterinary preparations for the treatment of envenomation by snakesdietetic foods adapted for medical usefood supplements containing vitaminsmineralstrace elementsoils and fatseither apart or in combinations thereof for use in the treatment of cardiovascular issuesvascular issues or cancerliquid medical sealantsliquid adhesives for use in surgical and clinical procedure ; pharmaceutical and medicinal preparations and substancesvaccines and vaccine adjuvantsproteinspeptidessera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomationoverdose of toxic substancessepsis; drug delivery agentspreparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals ; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposesvaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical and pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of digoxindigitalis and other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical and veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxindigitalis and other cardio-active glycoside toxicityfor use in the treatment of pre-eclampsia; chemical preparations for medical and pharmaceutical purposes and medicines for use in the treatment of digoxindigitalis and other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolisation pharmaceutical preparationsvaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancestherapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposesbeads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; radiotherapy substances for medical purposesradioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticalsradiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beadsincluding microscopic radioactive beads featuring pharmaceutical preparations for treatment of cancerous tumours; beadsincluding microscopic glass beadsimpregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams and for use in preparing foamsfor sclerotherapyphlebologyangiology and proctologyfor the treatment of oesophageal variceshydrocelesin sterilisation treatment and for treatment of varicose veinsarterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and for the treatment of autoimmune diseases ; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
Classe 10
Surgicalmedical and veterinary apparatus and instrumentsmedical syringessurgical and medical apparatus for producing and administering pharmaceutical foamssurgical and medical apparatus for producing foams for treatment of varicose veinsarterio-venous malformationsoesophageal varices and hydrocelesdevices for intravenous administration of pharmaceutical foamdiagnostic devices for grading the severity of venous conditionssnake envenomation and toxic drugs overdose; surgicalmedical and veterinary apparatus and instrumentsmedical devices for use in pulmonary and thoracic surgery and procedureslung air trapping reduction coilslung volume reduction devicessurgical implants comprising artificial materialsurgical implants comprising artificial materials for restoringmaintaining and improving patient breathing and artificial surgical implants for restoringmaintaining and improving lung functioncatheters for deploying these; surgicalmedical and veterinary apparatus and instrumentsmedical deviceapparatus and instruments for treating cancer; drug delivery embolisation apparatusinstruments and systems ; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instrumentscathetersinjection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatusinstruments and systems comprising surgical and medical instruments for embolizationembolic devices for use in treating cancer and tumorsembolic devices for treating arteriovenous malformations (AVMs) of the bodyembolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instrumentsa drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolizationmedical devices in the nature of embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisationembolisation apparatusinstruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beadsmicroscopic radioactive glass beads administered surgically for treatment of cancerous tumours; radioactive beadsradioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system ; medical devices in the nature of drug delivery systems which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical usecannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veinsvenous malformationsarterio-venous malformationsoesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veinsvenous malformationsarterio-venous malformationsoesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veinsvenous malformationsarterio-venous malformationsoesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for use in sclerotherapyphlebologyangiology and proctology; syringes for producing and administering foams for use in sclerotherapyphlebologyangiology and proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veinsarterio-venous malformationsoesophageal varices and hycroceles; syringes for use in treatment of varicose veinsarterio-venous malformationsoesophageal varices and hydroceles; devices for assessing the physical characteristics of such foamsmedical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veinsvenous malformationsarterio-venous malformationsoesophageal varices and hydroceles; medical devices for monitoring the position and effect of sclerosing foam in the human body for the treatment of varicose veinsvenous malformationsarterio-venous malformationsoesophageal varices and hydroceles; medical diagnostic apparatus for diagnosing all the above medical conditionsvaricose veinsarterio-venous malformationsoesophageal varicesspider veins hydrocelescancertumorscirculatory system conditions and pulmonary and thoracic conditions; compression bandages; component parts and fittings for all of the aforesaid goods; irradiated or radioactive microspheres used for in vivo therapeutic medical purposesimplantable radiation therapy devices consisting of radioactive beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assemblybeads in the nature of microscopic radioactive beads for treatment of cancerous tumours and beads in the nature of radioactive microscopic glass beads for treatment of cancerous tumours; radioactive glass beadsimplantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly and implantable radiation therapy devices consisting of radioactive beads; radioactive glass beadsimplantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours
Publicações
Histórico de despachos e eventos da marca no USPTO.
72 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
29/07/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
29/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/07/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
26/05/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
24/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/07/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/04/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/04/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/03/2023
E815
TEAS SECTION 8 & 15 RECEIVED
28/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/04/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/04/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/08/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/08/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
24/05/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/04/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/08/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
29/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
24/05/2016
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
14/04/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2016
IUCN
NOTICE OF ALLOWANCE CANCELLED
22/02/2016
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
22/02/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/09/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/07/2015
PUBO
PUBLISHED FOR OPPOSITION
14/07/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/06/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/05/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/05/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/05/2015
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
13/04/2015
GPRA
PRIORITY ACTION E-MAILED
13/04/2015
CPRA
PRIORITY ACTION WRITTEN
13/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/03/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/03/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/03/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/11/2014
GNRT
NON-FINAL ACTION E-MAILED
21/11/2014
CNRT
NON-FINAL ACTION WRITTEN
21/11/2014
DOCK
ASSIGNED TO EXAMINER
14/11/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
30/08/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/08/2014
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
28/08/2014
ALIE
ASSIGNED TO LIE
21/08/2014
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/08/2014
NWAP
NEW APPLICATION ENTERED
21/08/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BTG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.